Gradient Investments’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,121
Closed -$15K 1522
2022
Q3
$15K Buy
+1,121
New +$16.6K ﹤0.01% 712

Other funds holding BCAT

Gradient Investments's BCAT Position: Q4 2022 in Review

Gradient Investments sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q4 2022, closing a stake of 1,121 shares — an estimated $15K sold.

Gradient Investments first reported a position in BCAT in Q3 2022 and held it in 1 quarter. The position peaked at $15K in Q3 2022. 85 funds tracked by Wall St. Rank hold BCAT as of Q4 2022.

  • Gradient Investments reported no remaining BlackRock Capital Allocation Term Trust position as of Q4 2022 after selling out during the quarter.
  • Gradient Investments sold 1,121 BlackRock Capital Allocation Term Trust shares in Q4 2022, an estimated $15K.
  • Gradient Investments first reported a position in BlackRock Capital Allocation Term Trust in Q3 2022 and held it in 1 quarter.
  • Gradient Investments's BlackRock Capital Allocation Term Trust position peaked at $15K in Q3 2022.
  • 85 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q4 2022.

Based on Gradient Investments's 13F filing for Q4 2022, filed 10 Jan 2023.